Key points from article :
Mayo Clinic and Oxford Nanopore join forces to revolutionise clinical testing.
Their collaboration aims to develop new clinical tests for diseases, including cancer.
Oxford Nanopore's innovative nanopore sequencing technology is at the forefront.
The collaboration enhances patient care by providing timely and accurate insights.
The research focuses on methylation and hard-to-characterise genetic conditions.
Activities are set to unfold at Mayo Clinic’s campus in Rochester, Minnesota.
